title: The association of the kynurenine pathway of tryptophan metabolism with acute brain dysfunction during critical illness*.
abstract: OBJECTIVE
  Plasma tryptophan levels are associated with delirium in critically ill patients. Although tryptophan has been linked to the pathogenesis of other neurocognitive diseases through metabolism to neurotoxins via the kynurenine pathway, a role for kynurenine pathway activity in intensive care unit brain dysfunction (delirium and coma) remains unknown. This study examined the association between kynurenine pathway activity as determined by plasma kynurenine concentrations and kynurenine/tryptophan ratios and presence or absence of acute brain dysfunction (defined as delirium/coma-free days) in intensive care unit patients.
  
  
  METHODS
  This was a prospective cohort study that utilized patient data and blood samples from the Maximizing Efficacy of Targeted Sedation and Reducing Neurologic Dysfunction trial, which compared sedation with dexmedetomidine vs. lorazepam in mechanically ventilated patients.
  
  
  RESULTS
  Baseline plasma kynurenine and tryptophan concentrations were measured using high-performance liquid chromatography with or without tandem mass spectrometry. Delirium was assessed daily using the Confusion Assessment Method for the Intensive Care Unit. Linear regression examined associations between kynurenine pathway activity and delirium/coma-free days after adjusting for sedative exposure, age, and severity of illness. Among 84 patients studied, median age was 60 yrs and Acute Physiology and Chronic Health Evaluation II score was 28.5. Elevated plasma kynurenine and kynurenine/tryptophan ratio were both independently associated with significantly fewer delirium/coma-free days (i.e., fewer days without acute brain dysfunction). Specifically, patients with plasma kynurenine or kynurenine/tryptophan ratios at the 75th percentile of our population had an average of 1.8 (95% confidence interval 0.6-3.1) and 2.1 (95% confidence interval 1.0-3.2) fewer delirium/coma-free days than those patients with values at the 25th percentile (p = .006 and p < .001, respectively).
  
  
  CONCLUSIONS
  Increased kynurenine pathway activation, assessed by plasma kynurenine and kynurenine/tryptophan ratio, was associated with fewer days alive and without acute brain dysfunction in intensive care unit patients. Future studies are warranted to clarify this relationship and investigate potential therapeutic interventions.
authors.affiliation: Vanderbilt University School of Medicine, Nashville, TN, USA.
authors.forename: Jessica R
authors.initials: JR
authors.lastname: Adams Wilson
authors.forename: Alessandro
authors.initials: A
authors.lastname: Morandi
authors.forename: Timothy D
authors.initials: TD
authors.lastname: Girard
authors.forename: Jennifer L
authors.initials: JL
authors.lastname: Thompson
authors.forename: Chad S
authors.initials: CS
authors.lastname: Boomershine
authors.forename: Ayumi K
authors.initials: AK
authors.lastname: Shintani
authors.forename: E Wesley
authors.initials: EW
authors.lastname: Ely
authors.forename: Pratik P
authors.initials: PP
authors.lastname: Pandharipande
mesh_terms: D000208:Acute Disease; D000368:Aged; D001927:Brain Diseases / Q000209:etiology*; D016638:Critical Illness; D005260:Female; D006801:Humans; D007737:Kynurenine / Q000097:blood / Q000502:physiology*; D008297:Male; D053858:Metabolic Networks and Pathways; D008875:Middle Aged; D011446:Prospective Studies; D014364:Tryptophan / Q000097:blood / Q000378:metabolism*
chemical_list: D007737:Kynurenine; D014364:Tryptophan
references.citation: Eur J Neurol. 2006 Jan;13(1):30-42
references.pmid: 16420391
references.citation: Eur J Immunol. 2001 Aug;31(8):2313-8
references.pmid: 11477543
references.citation: Anticancer Res. 2002 Mar-Apr;22(2A):931-6
references.pmid: 12014674
references.citation: Psychosomatics. 1994 Jul-Aug;35(4):374-91
references.pmid: 7916159
references.citation: JAMA. 2004 Apr 14;291(14):1753-62
references.pmid: 15082703
references.citation: Neuroimmunomodulation. 2005;12(1):60-6
references.pmid: 15756054
references.citation: J Neurochem. 2008 May;105(4):1346-57
references.pmid: 18221377
references.citation: Neuropsychol Rev. 2004 Jun;14(2):87-98
references.pmid: 15264710
references.citation: Am J Respir Crit Care Med. 2002 Nov 15;166(10):1338-44
references.pmid: 12421743
references.citation: Intensive Care Med. 2007 Jan;33(1):66-73
references.pmid: 17102966
references.citation: Biochim Biophys Acta. 1977 Mar 29;497(1):1-13
references.pmid: 321035
references.citation: Glia. 1995 Jan;13(1):45-50
references.pmid: 7751055
references.citation: Age Ageing. 2007 Mar;36(2):222-5
references.pmid: 17114198
references.citation: Med Hypotheses. 2004;63(3):402-6
references.pmid: 15288356
references.citation: J Psychopharmacol. 2009 May;23(3):287-94
references.pmid: 18562404
references.citation: J Neurol Sci. 1992 Mar;108(1):80-7
references.pmid: 1385624
references.citation: Crit Care Med. 2004 Apr;32(4):955-62
references.pmid: 15071384
references.citation: Intensive Care Med. 2009 Nov;35(11):1886-92
references.pmid: 19588122
references.citation: Crit Care. 2010;14(5):199
references.pmid: 21067627
references.citation: J Neurochem. 2002 Jul;82(2):258-68
references.pmid: 12124427
references.citation: J Neurol Sci. 2007 Jun 15;257(1-2):221-39
references.pmid: 17462670
references.citation: Neuropathol Appl Neurobiol. 2005 Aug;31(4):395-404
references.pmid: 16008823
references.citation: Redox Rep. 2002;7(4):199-206
references.pmid: 12396664
references.citation: J Am Geriatr Soc. 2003 May;51(5):591-8
references.pmid: 12752832
references.citation: J Gerontol A Biol Sci Med Sci. 2006 Dec;61(12):1294-9
references.pmid: 17234823
references.citation: JAMA. 2001 Dec 5;286(21):2703-10
references.pmid: 11730446
references.citation: Brain Cogn. 2010 Oct;74(1):18-23
references.pmid: 20580479
references.citation: J Trauma. 2008 Jul;65(1):34-41
references.pmid: 18580517
references.citation: Anesthesiology. 2006 Jan;104(1):21-6
references.pmid: 16394685
references.citation: Intensive Care Med. 2001 May;27(5):859-64
references.pmid: 11430542
references.citation: Med Hypotheses. 1999 Aug;53(2):103-6
references.pmid: 10532699
references.citation: Crit Care Med. 2010 Jul;38(7):1513-20
references.pmid: 20473145
references.citation: Intensive Care Med. 2001 Dec;27(12):1892-900
references.pmid: 11797025
references.citation: J Cereb Blood Flow Metab. 1998 Jun;18(6):610-5
references.pmid: 9626184
references.citation: J Mass Spectrom. 2008 Jan;43(1):42-52
references.pmid: 17683023
references.citation: Am J Respir Crit Care Med. 2009 Dec 1;180(11):1092-7
references.pmid: 19745202
references.citation: J Geriatr Psychiatry Neurol. 1998 Fall;11(3):138-45; discussion 157-8
references.pmid: 9894732
references.citation: Ann N Y Acad Sci. 2007 Dec;1122:35-49
references.pmid: 18077563
references.citation: Crit Care Med. 1985 Oct;13(10):818-29
references.pmid: 3928249
references.citation: PLoS One. 2009 Jul 22;4(7):e6344
references.pmid: 19623258
references.citation: Crit Care Med. 2010 Dec;38(12):2311-8
references.pmid: 20838332
references.citation: Pharmacol Rev. 1993 Sep;45(3):309-79
references.pmid: 8248282
references.citation: Crit Care Clin. 2008 Jan;24(1):45-65, viii
references.pmid: 18241778
references.citation: Acta Neuropathol. 2010 Jun;119(6):737-54
references.pmid: 20309566
references.citation: Crit Care Med. 1998 Nov;26(11):1793-800
references.pmid: 9824069
references.citation: Ann Neurol. 1991 Feb;29(2):202-9
references.pmid: 1826418
references.citation: J Gerontol A Biol Sci Med Sci. 2006 Dec;61(12):1277-80
references.pmid: 17234820
references.citation: Expert Opin Ther Targets. 2009 Feb;13(2):247-58
references.pmid: 19236242
references.citation: J Chromatogr B Biomed Appl. 1995 Jul 21;669(2):177-86
references.pmid: 7581894
references.citation: Neurodegener Dis. 2005;2(3-4):166-76
references.pmid: 16909022
references.citation: Int J Geriatr Psychiatry. 2010 Mar;25(3):234-9
references.pmid: 19575407
references.citation: Crit Care Med. 2001 Jul;29(7):1370-9
references.pmid: 11445689
references.citation: Int J Tryptophan Res. 2009;2:1-19
references.pmid: 22084578
references.citation: Neurochem Res. 1980 Mar;5(3):223-39
references.pmid: 6154900
references.citation: J Neurochem. 1990 Jul;55(1):338-41
references.pmid: 2141357
references.citation: Free Radic Res. 2004 Nov;38(11):1167-71
references.pmid: 15621693
references.citation: Crit Care. 2008;12(3):R63
references.pmid: 18457586
references.citation: Crit Care Clin. 2008 Oct;24(4):789-856, ix
references.pmid: 18929943
references.citation: Clin Chim Acta. 2006 Feb;364(1-2):82-90
references.pmid: 16139256
references.citation: Crit Care Med. 2004 Nov;32(11):2254-9
references.pmid: 15640638
references.citation: Semin Clin Neuropsychiatry. 2000 Apr;5(2):125-31
references.pmid: 10837101
references.citation: JAMA. 2003 Jun 11;289(22):2983-91
references.pmid: 12799407
references.citation: Brain. 1992 Oct;115 ( Pt 5):1249-73
references.pmid: 1422788
references.citation: JAMA. 2007 Dec 12;298(22):2644-53
references.pmid: 18073360
references.citation: Adv Exp Med Biol. 2003;527:455-63
references.pmid: 15206763
references.citation: Epilepsia. 1990 Mar-Apr;31(2):172-7
references.pmid: 1690639
references.citation: J Pharmacol Exp Ther. 2002 Oct;303(1):1-10
references.pmid: 12235226
references.citation: J Neurochem. 1991 Jun;56(6):2007-17
references.pmid: 1827495
references.citation: J Neurovirol. 2001 Feb;7(1):56-60
references.pmid: 11519483
references.citation: Crit Care. 2005 Aug;9(4):R375-81
references.pmid: 16137350